📰 Greg Molnar News
Greg Molnar News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Greg Molnar. Real-time updates on events, politics, business and more.
January 9, 2023
/PRNewswire/ -- Justin Zenanko, CEO of SynerFuse, Inc., a Minnesota-based medical device company, is pleased to announce that for the first time in the world,...
January 9, 2023
--Study to Evaluate Safety and Tolerability of Simultaneous Implant of Spinal Fusion and Neuromodulation Devices in Chronic Lower Back Pain Patien...
October 18, 2022
/PRNewswire/ -- SynerFuse, Inc., an Eden Prairie, Minnesota-based medical device company, announced today that an independent Data Safety and Monitoring Board...
February 15, 2022
MINNEAPOLIS, Feb. 15, 2022 /PRNewswire/ -- SynerFuse, Inc., a privately held, clinical-stage medical device company focused on the development of ...
January 13, 2022
MINNEAPOLIS, Jan. 13, 2022 /PRNewswire/ -- SynerFuse, Inc., a Minneapolis-based medical device company, is pleased to announce the first implantat...
August 16, 2021
/PRNewswire/ -- SynerFuse released a two-year global patent search demonstrating that the 12-person Minnesota-based startup is a "Top 10" neuromodulation...
March 4, 2021
Share this article Share this article MINNEAPOLIS, March 4, 2021 /PRNewswire/ -- SynerFuse™, a developer of a novel implantable neurostimulator intended to treat chronic low-back pain without the use of addictive opioids, today announced a strategic development and manufacturing relationship with Cirtec Medical Corporation to support their current investigational and future commercial technology needs. The partnership is focused on the development of the NeuroFuse™ DRG therapy, which uniq...
February 2, 2021
Skip to main content Currently Reading Cirtec completes Device Master File (MAF) for their recent acquisition of the Nuvectra Algovita Spinal Cord Stimulation System PRWeb FacebookTwitterEmail MINNEAPOLIS (PRWEB) February 01, 2021 Cirtec Medical Corporation, a strategic outsourcing partner for complex medical devices including active implantables, minimally invasive devices and novel catheter-based delivery systems, today announced a sponsor-initiated withdrawal of the premarket approval (PMA) ...